Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −51,488 0
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −18,905 18,906
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +140,750 140,750
2022-03-04 Drape Eric Executive VP Global Operations Option exercise +32,518 78,348
2022-03-04 Drape Eric Executive VP Global Operations Sale −17,157 $7.48 $128K 61,191
2022-03-04 Drape Eric Executive VP Global Operations Option exercise +11,940 73,131
2022-03-04 Drape Eric Executive VP Global Operations Sale −6,301 $7.48 $47K 66,830
2022-03-04 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −32,518 0
2022-03-04 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −11,940 11,940
2022-03-04 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +134,048 134,048
2022-03-04 Dethlefs Sven EVP, North America Commercial Option exercise +37,939 137,396
2022-03-04 Dethlefs Sven EVP, North America Commercial Option exercise +13,930 151,326
2022-03-04 Dethlefs Sven EVP, North America Commercial Sale −3,904 $7.48 $29K 147,422
2022-03-04 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −37,939 0
2022-03-04 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −13,930 13,931
2022-03-04 Dethlefs Sven EVP, North America Commercial Grant or award · Restricted Share Units +154,155 154,155
2022-03-04 Daniell Richard Exec. VP, European Commercial Option exercise +15,920 36,200
2022-03-04 Daniell Richard Exec. VP, European Commercial Sale −15,920 $7.48 $119K 20,280
2022-03-04 Daniell Richard Exec. VP, European Commercial Option exercise +43,358 63,638
2022-03-04 Daniell Richard Exec. VP, European Commercial Sale −20,456 $7.48 $153K 43,182

Page 39 of 76 · 1,517 trades